| Thanks to Lead SoCalBio Sponsors |  |
Take Advantage of SoCalBio's Group Purchasing Program to Cut the Cost of Doing Business Vendor ShowcaseFor Document Storage, Management and Disposal Services |
Looking for Help Finding Talent? | |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
| Thanks to all the Participants  A toast from SoCalBio's staff to all those who made this event
a smashing success in a difficult economy Conference photo slide show is available at: |
Upcoming SoCalBio Business Mixers | - September 30, 4:00 - 7:00 pm
 SoCalBio Networking Forum in Ventura County (Westlake Village Inn)
Focus: Innovation and Protecting Your Intellectual Property in a Changing Patent Regime ... More Info
Focus: Why Bioscience Companies Should Care About Social Media ... More Info
|
| Grants | Molecular Express Announces Award of Phase I SBIR Funding to Continue Development of an Influenza Vaccine The Dominguez Hill-Based biotech company will conduct part of the influenza vaccine project in collaboration with Professors Thomas Voss at Tulane University and Christopher Miller of the California National Primate Research Center at the University of California Davis. Read more |
| Research Milestone | ImmunoCellular Therapeutics Announces Successful Humanization of Two Antibody Candidates
The Woodland Hills-based biotech company said it has completed humanization of ICT-37 and ICT-109. This humanization was done in collaboration with
Antitope, a privately held, UK based biotechnology company providing services in the areas of immunogenicity testing, antibody humanization and protein engineering for the purpose of reducing immunogenicity with therapeutic monoclonal antibodies. The collaboration has resulted in two novel antibodies targeting CEACAM5 alone and CEACAM5 and CEACAM6, two commonly expressed genes present in malignant cells specific to colon cancer, small cell lung cancer and pancreatic cancer.... Read more |
| Finance | Spectrum Pharmaceuticals to Raise up to $50 Million from Institutional Investors at $7.55 Per Share The Irvine-based company will use the proceeds from the transaction for general corporate purposes.... Read more |
| Collaborations | California Stem Cell
(CSC) and Stemina Biomarker Discovery Announce Collaboration Agreement The impetus behind the CSC and Stemina collaboration was to develop a predictive assay to screen for
cardiotoxicity, using a variety of anti-cancer drugs with different and distinct mechanisms of action on human cardiac tissue that are known to induce cardiotoxicity and potentially
cardiomyopathy, said California Stem Cell President Chris
Airriess.... Read more ImmunoCellular: What's Next After Roche Deal? The Roche deal validates IMUC's pipeline potential and is impressive given that ICT-69 is very early in preclinical development and is about two years away from evaluation in clinical trials... Read more |
| Clinical Studies |  The Calabasas-Based KYTHERA Biopharmaceuticals Announces Initiation of First-in-Human Trial for ATX-104 - A Light-Activated Facial Contouring Agent
"The initiation of this ATX-104 trial marks an important milestone for
KYTHERA. ATX-104 represents our third clinical stage product and the first based on our own Research programs," said Keith Leonard, President and CEO of KYTHERA (photo right). "With the data from this initial proof-of-concept trial, we intend to evaluate worldwide partnership options for ATX-104" .... Read more Edwards Percutaneous Valve: 64% Survivalin High-Risk Patients Nearly two-thirds of high-risk patients who received an Edwards Lifesciences Corp
(EW.N) aortic heart valve through a less-invasive procedure were alive two years after the treatment, Edwards reported on September 21... Read more |
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
Editor:
